(Q38850240)

7 September 2017

1 reference

title

The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam (English)

1 reference

7 September 2017

Christopher J. Schofield

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

David Y Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Martine I. Abboud

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Marios S Markoulides

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jürgen Brem

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

4

Jürgen Brem

1 reference

7 September 2017

21 June 2016

1 reference

Future Medicinal Chemistry

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

1063-1084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Antibiotics in the clinical pipeline in 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Diversity of the mechanisms of resistance to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Cutting and stitching: the cross-linking of peptidoglycan in the assembly of the bacterial cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The importance of efflux pumps in bacterial antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Metallo-β-lactamases: a last frontier for β-lactams?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The beta-lactamase cycle: a tale of selective pressure and bacterial ingenuity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The mechanisms of catalysis by metallo beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

A variety of roles for versatile zinc in metallo-β-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Targeting metallo-β-lactamase enzymes in antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Inhibition of elastase by N-sulfonylaryl beta-lactams: anatomy of a stable acyl-enzyme complex

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Penicillin-binding proteins and beta-lactam resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Mechanism of action of β-lactam antibiotics at the molecular level

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Beta-Lactam antibiotic resistance in gram-positive bacterial pathogens of the upper respiratory tract: a brief overview of mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structure of PBP-A from Thermosynechococcus elongatus, a penicillin-binding protein closely related to class A beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Tebipenem, a New Carbapenem Antibiotic, Is a Slow Substrate That Inhibits the β-Lactamase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Penicillin and cephalosporin biosynthetic genes: structure, organization, regulation, and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The enzymology of clavam and carbapenem biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Beta-lactams in the new millennium. Part-I: monobactams and carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Hydrolytic stability versus ring size in lactams: implications for the development of lactam antibiotics and other serine protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

5,5-Fused thiophene gamma-lactams as templates for serine protease inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Updated functional classification of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Three decades of beta-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

21 January 2018

b-Lactamase inhibitors

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

"Mind the Gap": Raman Evidence for Rapid Inactivation of CTX-M-9 β-Lactamase Using Mechanism-Based Inhibitors that Bridge the Active Site

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Following the Reactions of Mechanism-Based Inhibitors with β-Lactamase by Raman Crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The Importance of thetrans-Enamine Intermediate as a β-Lactamase Inhibition Strategy Probed in Inhibitor-Resistant SHV β-Lactamase Variants

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structure

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The Allosteric Site for the Nascent Cell Wall in Penicillin-Binding Protein 2a: An Achilles' Heel of Methicillin-Resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Molecular structure of the acyl-enzyme intermediate in beta-lactam hydrolysis at 1.7 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The Tipper-Strominger Hypothesis and Triggering of Allostery in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus (MRSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Bacterial cell wall synthesis and structure in relation to the mechanism of action of penicillins and other antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Restricting the ψ Torsion Angle Has Stereoelectronic Consequences on a Scissile Bond: An Electronic Structure Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

A computational evaluation of the mechanism of penicillin-binding protein-catalyzed cross-linking of the bacterial cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Conformation of penicillin as a transition-state analog of the substrate of peptidoglycan transpeptidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Transition state structures of a dipeptide related to the mode of action of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin".

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Mechanistic insights into the inhibition of serine proteases by monocyclic lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structural basis for the interaction of lactivicins with serine beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam template

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Pyrrolidine-5,5-trans-lactams. 1. Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A protease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Interaction of clavulanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Chemical studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Development of new drugs for an old target: the penicillin binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Beta-sultams-mechanism of reactions and use as inhibitors of serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Novel Insights into the Mode of Inhibition of Class A SHV-1 -Lactamases Revealed by Boronic Acid Transition State Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Crystal structure of Enterobacter cloacae 908R class C beta-lactamase bound to iodo-acetamido-phenyl boronic acid, a transition-state analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

The deacylation mechanism of AmpC beta-lactamase at ultrahigh resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Design and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-Lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Crystal Structures of KPC-2 -Lactamase in Complex with 3-Nitrophenyl Boronic Acid and the Penam Sulfone PSR-3-226

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structural study of phenyl boronic acid derivatives as AmpC β-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Practical and cost-effective manufacturing route for the synthesis of a β-lactamase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized stud

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Improving known classes of antibiotics: an optimistic approach for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

New β-lactam antibiotics and β-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Enantioselective Synthesis and Profiling of Two Novel Diazabicyclooctanone β-Lactamase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

β-Lactamase inhibitors: a review of the patent literature (2010 - 2013).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Fragment-guided design of subnanomolar -lactamase inhibitors active in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Novel natural product 5,5-trans-lactone inhibitors of human alpha-thrombin: mechanism of action and structural studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Action of strigolactones in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Kinetics of avibactam inhibition against Class A, C, and D β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC -Lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Investigations on recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structural and Biochemical Characterization of the Interaction between KPC-2 β-Lactamase and β-Lactamase Inhibitor Protein,

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

In vitro activities of ceftazidime-avibactam and aztreonam-avibactam against 372 Gram-negative bacilli collected in 2011 and 2012 from 11 teaching hospitals in China

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Carbapenemases: the versatile beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

In Vitro and In Vivo Activities of OP0595, a New Diazabicyclooctane, against CTX-M-15-Positive Escherichia coli and KPC-Positive Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

In vitro and in vivo activities of AM-112, a novel oxapenem.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Alkylidene Oxapenem β-Lactamase Inhibitors Revisited: Potent Broad Spectrum Activity but New Stability Challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Structural Analyses on Intermediates in Serine Protease Catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Inactivation of TEM-1 by Avibactam (NXL-104): Insights from Quantum Mechanics/Molecular Mechanics Metadynamics Simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Lactivicin – ein Antibiotikum gegen Penicillin-resistente Pneumokokken

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

Binding of a non- β -lactam antibiotic to penicillin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC-2016-0078

21 January 2018

Identifiers

DOI

10.4155/FMC-2016-0078

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327972%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference